The trademark application GPSS was filed by Acurx Pharmaceuticals, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on March 7, 2022, and it was registered by office on June 14, 2022 without any oppositions.
The application was filed in English (German was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on October 4, 2022.